SNCA and Parkinson disease: Furthermore, we confirmed our results through confocal microscopy, which showed the increased immunoreactivity of α-synuclein in the striatum and SNpc of PD mice, and treatment with Trolox decreased the immunoreactivity of α-synuclein in the brain of PD mice (Figure 2b).